Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 3 7Phase 2 7Phase 4 2Phase 1 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 1/2 1

Status

Completed 15Withdrawn 9Recruiting 7Unknown 5Terminated 4Active not recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 7

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 2Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Trauma, Nervous System 1Schwannomatosis 1Pain 1Neurilemmoma 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Mesothelioma 1Lymphoma, Follicular 1Lung Neoplasms 1Intracranial Hemorrhages 1Fatigue 1Chronic Pain 1Carcinoma, Hepatocellular 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1Brain Injuries, Traumatic 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Saline Solution × Clear all
NCT07219459 2026-04-27

GDFATHERHCC01

CatalYm GmbH

Phase 2 Recruiting
104 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05684692 2026-04-23

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Massachusetts General Hospital

Phase 2 Recruiting
40 enrolled

Schwannomatosis, Neurilemmoma, Pain, Chronic Pain

NCT07246863 2026-04-21

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

CatalYm GmbH

Phase 2 Recruiting
131 enrolled
Other solid neoplasmThoracic

Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT05849129 2026-01-23

AIVAA

The Canadian College of Naturopathic Medicine

Phase 2 Recruiting
90 enrolled
Thoracic

Lung Neoplasms

NCT05730816 2025-11-21

MAGIC-AKI

Brigham and Women's Hospital

Phase 2 Recruiting
130 enrolled
Other solid neoplasmThoracic

Mesothelioma

NCT05951777 2025-09-29

Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

Hope Biosciences Research Foundation

Phase 2 Recruiting
51 enrolled
Lymphoid

Brain Injuries, Traumatic, Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Trauma, Nervous System, Intracranial Hemorrhages

NCT05440227 2025-06-05

PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

PhytoHealth Corporation

Phase 2 Recruiting
36 enrolled
Breast

Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡